Inducible pluripotent stem cell models to study bone marrow failure and MDS predisposition syndromes

Area of Science:

• Hematology
• Stem Cell Biology
• Genetics

Background:

• Inherited bone marrow failure (BMF) syndromes and myelodysplastic syndromes (MDS) predispose individuals to acute myeloid leukemia (AML).
• Induced pluripotent stem cells (iPSCs) offer a powerful platform for modeling these complex hematopoietic disorders in vitro.
• Understanding the genetic basis and pathomechanisms of these conditions is crucial for developing effective therapies.

Purpose of the Study:

• To review recent advancements in iPSC-based disease modeling for inherited BMF/MDS disorders.
• To highlight how iPSC models recapitulate disease phenotypes and enhance understanding of pathomechanisms.
• To discuss challenges, limitations, and future directions of iPSC technology in this field.

Main Methods:

• Synthesis of recent literature on iPSC applications in modeling inherited BMF/MDS.
• Analysis of iPSC-derived hematopoietic differentiation, telomere dysfunction, DNA repair, and ribosome biogenesis.
• Examination of patient-derived iPSCs and genetically engineered iPSC lines with patient-specific mutations.

Main Results:

• iPSC models successfully recapitulate key disease phenotypes, including impaired hematopoiesis and molecular defects.
• These models have elucidated disease pathomechanisms and identified potential therapeutic targets.
• Advances include using isogenic controls to clarify genotype-phenotype relationships.

Conclusions:

• iPSC technology is significant for understanding inherited hematopoietic disorders and developing novel therapeutic strategies.
• iPSC models hold promise for drug discovery and personalized medicine approaches for BMF/MDS.
• Addressing challenges in iPSC generation, maintenance, and in vivo validation is essential for future progress.